Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid, CA Cancer J Clin, vol.40, issue.5, pp.299-317, 1990. ,
Implications of Na+/I-Symporter Transport to the Plasma Membrane for Thyroid Hormonogenesis and Radioiodide Therapy, J Endocr Soc, vol.3, issue.1, pp.222-256, 2019. ,
Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy, p.7 ,
Short-Term Side Effects after Radioiodine Treatment in Patients with Differentiated Thyroid Cancer, BioMed Research International, vol.2016, pp.1-5, 2016. ,
Complications of Radioactive Iodine Treatment of Thyroid Carcinoma, vol.8, pp.1277-87, 2010. ,
Prediction of risk for symptomatic sialadenitis by post-therapeutic dual 131I scintigraphy in patients with differentiated thyroid cancer, Annals of Nuclear Medicine, vol.27, issue.8, pp.700-709, 2013. ,
Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer, Clinical Oncology, vol.19, issue.1, pp.83-89, 2007. ,
Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma: Nuclear Medicine Communications, 2001. ,
Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study, Head & Neck, vol.39, issue.12, pp.2381-96, 2017. ,
Salivary evaluation in radioactive I 131 treated patients with thyroid carcinoma, Acta Odontologica Scandinavica, vol.76, issue.2, pp.148-52, 2018. ,
Radioactive iodine: An unappreciated threat to salivary gland function, Oral Diseases, vol.24, issue.1-2, pp.198-201, 2018. ,
Sialoadenitis por radioyodo. Análisis de factores que influyen en la respuesta al tratamiento médico. Endocrinología y Nutrición, vol.62, pp.493-501, 2015. ,
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Supportive Care in Cancer, vol.18, pp.1039-60, 2010. ,
Second primary malignancies in thyroid cancer patients, British Journal of Cancer, vol.89, issue.9, pp.1638-1682, 2003. ,
URL : https://hal.archives-ouvertes.fr/inserm-00122276
Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma -A systematic review, Cancer Treatment Reviews, vol.41, issue.10, pp.925-959, 2015. ,
Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy, Future Oncology, vol.9, issue.8, pp.1145-59, 2013. ,
Incidence of salivary side effects after radioiodine treatment using a new specificallydesigned questionnaire. British Journal of Oral and Maxillofacial Surgery, vol.55, pp.609-621, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01788386
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck, vol.33, pp.686-90, 2011. ,
Intermediate and Long-Term Side Effects of High-. Dose Radioiodine Therapy for Thyroid Carcinoma, p.5 ,
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer, Ann Nucl Med, vol.27, issue.4, pp.386-91, 2013. ,
Salivary Morbidity and Quality of Life following Radioactive Iodine for Well-Differentiated Thyroid Cancer. Otolaryngol Head Neck Surg, vol.148, pp.746-52, 2013. ,
, THYROID CANCER PATIENTS TREATED WITH RADIOIODINE, p.6
Therapeutic sialendoscopy for the management of radioiodine sialadenitis. Arch Otolaryngol Head Neck Surg, vol.138, pp.15-24, 2012. ,
Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer, International Journal of Endocrinology, vol.2016, pp.1-6, 2016. ,
Xerostomia in geriatric patients: a burgeoning global concern, J Investig Clin Dent, vol.7, issue.1, pp.5-12, 2016. ,
Self-reported dry mouth in 50-to 80-year-old Swedes: Longitudinal and cross-sectional population studies, J Oral Rehabil, 2019. ,
,
, Rev Prat, vol.51, issue.2, pp.177-80, 2001.
A 15-yr longitudinal study of xerostomia in a Swedish population of 50-yr-old subjects. European journal of oral sciences, vol.117, pp.13-22, 2009. ,
Self-reported dry mouth in Swedish population samples aged 50, 65 and 75 years, Gerodontology, vol.29, issue.2, pp.107-122, 2012. ,
Age-related changes in human sublingual glands: a post mortem study, Arch Oral Biol, vol.50, issue.6, pp.565-74, 2005. ,
Replacement of functional parenchymal cells by fat and connective tissue in human submandibular salivary glands: an age-related change, J Oral Pathol, vol.2, issue.1, pp.16-27, 1973. ,
Salivary Gland Function 5 Years After Radioactive Iodine Ablation in Patients with Differentiated Thyroid Cancer: Direct Comparison of Pre-and Postablation Scintigraphies and Their Relation to Xerostomia Symptoms, Thyroid, vol.23, issue.5, pp.609-625, 2013. ,
Changing Trends in the Incidence of Thyroid Cancer in the United States, JAMA Otolaryngol Head Neck Surg, vol.142, issue.7, pp.709-720, 201601. ,
Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer. Pediatr Blood Cancer, vol.64, p.26595, 2017. ,
Long-Term Effects of Radioiodine Treatment on Salivary Gland Function in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma, J Nucl Med, vol.60, issue.2, pp.172-179, 2019. ,
SEOM clinical guidelines for the treatment of thyroid cancer, Clin Transl Oncol, vol.13, issue.8, pp.574-583, 2011. ,
Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology, Endocrinol Metab (Seoul), vol.29, issue.3, pp.233-242, 2014. ,
Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy ,
, Rofo, vol.125, issue.6, pp.546-51, 1976.
131I therapy in differentiated thyroid carcinoma: M. D. Anderson Hospital experience. Cancer, vol.47, pp.664-71, 1981. ,
Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction, Thyroid, vol.24, issue.12, pp.1806-1820, 2014. ,
On the mechanism of salivary gland radiosensitivity, Int J Radiat Oncol Biol Phys, vol.62, issue.4, pp.1187-94, 2005. ,
Does Lemon Candy Decrease Salivary Gland Damage After Radioiodine Therapy for Thyroid Cancer, p.7 ,
Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?: Nuclear Medicine Communications, vol.35, pp.210-216, 2014. ,
Chewinggum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imaging, EJNMMI Phys, vol.1, issue.1, p.100, 2014. ,
Protective effects of curcumin on radioiodine-induced salivary gland dysfunction in mice, J Tissue Eng Regen Med, vol.13, issue.4, pp.674-81, 2019. ,
Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine: Nuclear Medicine Communications, vol.39, pp.430-434, 2018. ,
Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial, Nuclear Medicine Communications, vol.38, issue.11, pp.891-903, 2017. ,
Botulinum Toxin Confers Radioprotection in Murine Salivary Glands, International Journal of Radiation Oncology*Biology*Physics, vol.94, issue.5, pp.1190-1197, 2016. ,
Costeffectiveness of follow-up contact for a postal survey: a randomised controlled trial, Aust N Z J Public Health, vol.34, issue.5, pp.508-520, 2010. ,
Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy, Front Endocrinol (Lausanne), vol.6, p.100, 2015. ,
Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up: Nuclear Medicine Communications, vol.36, pp.819-845, 2015. ,
Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment: Clinical Nuclear Medicine, vol.27, pp.767-71, 2002. ,
Utility of two oral health-related quality-of-life measures in patients with xerostomia. Community dentistry and oral epidemiology, vol.34, pp.351-62, 2006. ,
Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36, Scandinavian journal of rheumatology, vol.29, issue.1, pp.20-28, 2000. ,
Quality of life and nutritional studies in Sjogren's syndrome patients with xerostomia. The New Zealand dental journal, vol.97, pp.128-159, 2001. ,
Health-related quality of life in patients with Primary Sjögren's Syndrome and Xerostomia: a comparative study, Gerodontology, vol.19, issue.1, pp.53-62, 2002. ,
, Cyrille Chossegros, vol.3, issue.1, p.3
Department of Maxillofacial surgery and stomatology of Pr Chossegros, 147 Boulevard Baille, 13005. ,
, SPMC EA, vol.3279, p.13284
Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid, CA Cancer J Clin, vol.40, issue.5, pp.299-317, 1990. ,
Implications of Na+/I-Symporter Transport to the Plasma Membrane for Thyroid Hormonogenesis and Radioiodide Therapy, J Endocr Soc, vol.3, issue.1, pp.222-256, 2019. ,
Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy, p.7 ,
Short-Term Side Effects after Radioiodine Treatment in Patients with Differentiated Thyroid Cancer, BioMed Research International, vol.2016, pp.1-5, 2016. ,
Complications of Radioactive Iodine Treatment of Thyroid Carcinoma, vol.8, pp.1277-87, 2010. ,
Prediction of risk for symptomatic sialadenitis by post-therapeutic dual 131I scintigraphy in patients with differentiated thyroid cancer, Annals of Nuclear Medicine, vol.27, issue.8, pp.700-709, 2013. ,
Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer, Clinical Oncology, vol.19, issue.1, pp.83-89, 2007. ,
Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma: Nuclear Medicine Communications, 2001. ,
Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study, Head & Neck, vol.39, issue.12, pp.2381-96, 2017. ,
Salivary evaluation in radioactive I 131 treated patients with thyroid carcinoma, Acta Odontologica Scandinavica, vol.76, issue.2, pp.148-52, 2018. ,
Radioactive iodine: An unappreciated threat to salivary gland function, Oral Diseases, vol.24, issue.1-2, pp.198-201, 2018. ,
Sialoadenitis por radioyodo. Análisis de factores que influyen en la respuesta al tratamiento médico. Endocrinología y Nutrición, vol.62, pp.493-501, 2015. ,
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Supportive Care in Cancer, vol.18, pp.1039-60, 2010. ,
Second primary malignancies in thyroid cancer patients, British Journal of Cancer, vol.89, issue.9, pp.1638-1682, 2003. ,
URL : https://hal.archives-ouvertes.fr/inserm-00122276
Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma -A systematic review, Cancer Treatment Reviews, vol.41, issue.10, pp.925-959, 2015. ,
Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy, Future Oncology, vol.9, issue.8, pp.1145-59, 2013. ,
Incidence of salivary side effects after radioiodine treatment using a new specificallydesigned questionnaire. British Journal of Oral and Maxillofacial Surgery, vol.55, pp.609-621, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01788386
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck, vol.33, pp.686-90, 2011. ,
Intermediate and Long-Term Side Effects of High-. Dose Radioiodine Therapy for Thyroid Carcinoma, p.5 ,
Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer, Ann Nucl Med, vol.27, issue.4, pp.386-91, 2013. ,
Salivary Morbidity and Quality of Life following Radioactive Iodine for Well-Differentiated Thyroid Cancer. Otolaryngol Head Neck Surg, vol.148, pp.746-52, 2013. ,
, THYROID CANCER PATIENTS TREATED WITH RADIOIODINE, p.6
Therapeutic sialendoscopy for the management of radioiodine sialadenitis. Arch Otolaryngol Head Neck Surg, vol.138, pp.15-24, 2012. ,
Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer, International Journal of Endocrinology, vol.2016, pp.1-6, 2016. ,
Xerostomia in geriatric patients: a burgeoning global concern, J Investig Clin Dent, vol.7, issue.1, pp.5-12, 2016. ,
Self-reported dry mouth in 50-to 80-year-old Swedes: Longitudinal and cross-sectional population studies, J Oral Rehabil, 2019. ,
,
, Rev Prat, vol.51, issue.2, pp.177-80, 2001.
A 15-yr longitudinal study of xerostomia in a Swedish population of 50-yr-old subjects. European journal of oral sciences, vol.117, pp.13-22, 2009. ,
Self-reported dry mouth in Swedish population samples aged 50, 65 and 75 years, Gerodontology, vol.29, issue.2, pp.107-122, 2012. ,
Age-related changes in human sublingual glands: a post mortem study, Arch Oral Biol, vol.50, issue.6, pp.565-74, 2005. ,
Replacement of functional parenchymal cells by fat and connective tissue in human submandibular salivary glands: an age-related change, J Oral Pathol, vol.2, issue.1, pp.16-27, 1973. ,
Salivary Gland Function 5 Years After Radioactive Iodine Ablation in Patients with Differentiated Thyroid Cancer: Direct Comparison of Pre-and Postablation Scintigraphies and Their Relation to Xerostomia Symptoms, Thyroid, vol.23, issue.5, pp.609-625, 2013. ,
Changing Trends in the Incidence of Thyroid Cancer in the United States, JAMA Otolaryngol Head Neck Surg, vol.142, issue.7, pp.709-720, 201601. ,
Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer. Pediatr Blood Cancer, vol.64, p.26595, 2017. ,
Long-Term Effects of Radioiodine Treatment on Salivary Gland Function in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma, J Nucl Med, vol.60, issue.2, pp.172-179, 2019. ,
SEOM clinical guidelines for the treatment of thyroid cancer, Clin Transl Oncol, vol.13, issue.8, pp.574-583, 2011. ,
Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology, Endocrinol Metab (Seoul), vol.29, issue.3, pp.233-242, 2014. ,
Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy ,
, Rofo, vol.125, issue.6, pp.546-51, 1976.
131I therapy in differentiated thyroid carcinoma: M. D. Anderson Hospital experience. Cancer, vol.47, pp.664-71, 1981. ,
Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction, Thyroid, vol.24, issue.12, pp.1806-1820, 2014. ,
On the mechanism of salivary gland radiosensitivity, Int J Radiat Oncol Biol Phys, vol.62, issue.4, pp.1187-94, 2005. ,
Does Lemon Candy Decrease Salivary Gland Damage After Radioiodine Therapy for Thyroid Cancer, p.7 ,
Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?: Nuclear Medicine Communications, vol.35, pp.210-216, 2014. ,
Chewinggum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imaging, EJNMMI Phys, vol.1, issue.1, p.100, 2014. ,
Protective effects of curcumin on radioiodine-induced salivary gland dysfunction in mice, J Tissue Eng Regen Med, vol.13, issue.4, pp.674-81, 2019. ,
Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine: Nuclear Medicine Communications, vol.39, pp.430-434, 2018. ,
Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial, Nuclear Medicine Communications, vol.38, issue.11, pp.891-903, 2017. ,
Botulinum Toxin Confers Radioprotection in Murine Salivary Glands, International Journal of Radiation Oncology*Biology*Physics, vol.94, issue.5, pp.1190-1197, 2016. ,
Costeffectiveness of follow-up contact for a postal survey: a randomised controlled trial, Aust N Z J Public Health, vol.34, issue.5, pp.508-520, 2010. ,
Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy, Front Endocrinol (Lausanne), vol.6, p.100, 2015. ,
Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up: Nuclear Medicine Communications, vol.36, pp.819-845, 2015. ,
Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment: Clinical Nuclear Medicine, vol.27, pp.767-71, 2002. ,
Utility of two oral health-related quality-of-life measures in patients with xerostomia. Community dentistry and oral epidemiology, vol.34, pp.351-62, 2006. ,
Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36, Scandinavian journal of rheumatology, vol.29, issue.1, pp.20-28, 2000. ,
Quality of life and nutritional studies in Sjogren's syndrome patients with xerostomia. The New Zealand dental journal, vol.97, pp.128-159, 2001. ,
Health-related quality of life in patients with Primary Sjögren's Syndrome and Xerostomia: a comparative study, Gerodontology, vol.19, issue.1, pp.53-62, 2002. ,